Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sware, formerly known as Boston Technology Research (BTR), is a private regulatory technology and life sciences software company focused on GxP and computer systems validation for healthcare, biotechnology, pharmaceutical, and software-enabled medical product organizations. Its core offering, Res_Q, is a cloud-native validation automation platform that helps customers centralize, automate, and maintain audit-ready compliance workflows. The company also provides validation consulting and managed services to support implementation, risk-based assessments, and ongoing compliance operations. Sware is not a therapeutics developer; instead, it sells commercial software and services that help life sciences companies reduce validation burden, accelerate technology adoption, and maintain inspection readiness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sware.